Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD).

BMJ open respiratory research - 9 Jun 2026

Schröder Niels, Andrä Jitka, Knuth-Rehr Diana, Leja Silke, Hunzelmann Nicolas, Börner Eda, Barbet Kimberly, Bonella Francesco

Abstract excerpt

BACKGROUND: Single nucleotide polymorphisms (SNPs) within Toll interacting protein (TOLLIP) coding gene have been associated with progression, prognosis and treatment response in idiopathic pulmonary fibrosis (IPF). These SNPs seem to influence mRNA expression and serum levels of TOLLIP. The aim of this study was to investigate TOLLIP serum concentrations in a previously genotyped cohort of patients with systemic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genotype

Share to Intracellular Signaling Peptides and Proteins

Share to Lung Diseases, Interstitial

Share to Polymorphism, Single Nucleotide

Share to Scleroderma, Systemic

Source

Open in PubMed Open full text

Identifiers

PMID: 42264885
DOI: 10.1136/bmjresp-2025-003962
PMCID: PMC13264915

Genes

TOLLIP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toll interacting protein (TOLLIP) serum concentration in patients with systemic sclerosis (SSc), with and without interstitial lung disease (ILD).PMID 42264885Read ↗

Toll interacting protein gene polymorphisms in patients with systemic sclerosis: association with interstitial lung disease, outcome, and survivalSemantic proximity Read ↗

Associations between genetic variants of Toll-interacting proteins and interstitial lung diseases: a systematic review and meta-analysis.Semantic proximity Read ↗

The immune landscape in SSc-ILD and tow genes are potential risk factors for pulmonary fibrosisSemantic proximity Read ↗

The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.Semantic proximity Read ↗

Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.Semantic proximity Read ↗

Toll interacting protein (TOLLIP) increases in fibrotic lung tissue of connective tissue disease-associated interstitial lung disease and is associated with clinical outcomeSemantic proximity Read ↗

Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary HypertensionSemantic proximity Read ↗

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.Semantic proximity Read ↗

Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks PrincipleSemantic proximity Read ↗

Alternative Gene Expression by TOLLIP Variant Is Associated With Lung Function in Chronic Hypersensitivity Pneumonitis.Semantic proximity Read ↗

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.Semantic proximity Read ↗

Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.